The Epstein-Barr virus (EBV) exhibits a marked tropism towards B-lymphocytes, where it proliferates, T-cells and lymphadenoids. Unlike other herpes viruses, it promotes proliferation of affected cells (generalized lymphadenopathy). EBV is one of oncogenic DNA-containing viruses and acts as an etiological agent for Burkitt lymphoma, nasopharyngeal carcinoma, some forms of lymphogranulomatosis, autoimmune diseases, etc.
Incubation period lasts 4 to 14 days, more seldom up to a month. Very often acute onset is reported: rise of body temperature, headache, muscular and joint pains. Patients suffer from soreness in the throat, the pain growing when swallowing, difficult nasal breathing, hyperplasia of lymphatic nodes. Intensity of clinical symptoms grows by day 4-6, but already by day 3-4 hepatolienal syndrome is observed, atypical mononuclear cells are found in the blood. The main symptoms are fever, tonsillitis, generalized lymphadenopathy, hepatosplenomegaly, exanthema (macular, roseolous, papular, etc.) . Mandibular and posterior cervical lymph nodes are affected more often, while axillary, inguinal and cubital ones are less often involved. In some patients rather evident picture of acute mesenteric lymphadenitis (mesadenitis) can be observed.
Specific changes in the peripheral blood occur after day 5 of the disease: leukocytosis is developing (hyperleukocytosis is possible, (18-20)·10 9 /L), lymphomonocytosis, the number of plasmocytes is increasing, atypical mononuclear cells are emerging (10-60% and higher). Recovery occurs in 2-4 weeks but lymphadenopathy, hepatosplenomegaly, atypical mononuclear cells may persist, which indicates prolonged disease progression.
There are several possible outcomes of the acute infectious process: recovery, asymptomatic viruscarriage or latent infection, chronic recurrent infection, chronic fatigue syndrome, development of an autoimmune disease and an oncological (lymphoproliferative) process (lymphogranulomatosis, multiple polyclonal lymphomas, nasopharyngeal carcinoma, leukoplakia of the tongue and oral cavity mucous membranes, gastrointestinal cancer, etc.).
Lymphogranulomatosis is a malignant lymphoid tissue neoplasm characterized by its granulomatous structure with presence of giant Reed-Sternberg cells, lesion of lymph nodes and viscera. The microscopic picture of lymphogranulomatosis is characterized by growth of lymphoid cells and plasmocytes, histiocytes, fibroblasts, neutrophil leukocytes, similar to granulomatous tissue. In the course of granulomatosis, giant Reed-Sternberg cells are found, whose specific features are giant-sized cytoplasm and nuclei; signs of nuclear division without cytoplasm division; large nucleoli resembling intranuclear inclusions; cell nuclei with a delicate chromatin network thickening to the periphery, which creates a clearing area in the centre of the nucleus.
Here is a clinical case that confirms the possibility of developing lymphoproliferative diseases and hematological malignancies after acute EBV infection.
Patient gave written informed consent for the scientific analysis of their data. (Figure 1 ). Axillary and inguinal glands were also enlarged (0.5-1 cm), painless, with a soft-elastic texture. In the oropharyngeal cavity there was hyperemia and hypertrophy of the tonsils, the lacunae were covered with purulent deposits (Figure 2) Follow-up and further treatment of the patient was carried out in the Oncologic Dispensary.
In the observation described above, lymphogranulomatosis can be estimated as an outcome of EBV infectious mononucleosis. Therefore, for accurate diagnosis and appropriate prediction of the EBV infection outcomes it is necessary to take into account and properly assess a wide variety of clinical symptoms and biochemical, immunological and morphological findings.
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